28448873|t|Osthole attenuates lipid accumulation, regulates the expression of inflammatory mediators, and increases antioxidants in FL83B cells
28448873|a|Osthole is found in Cnidium monnieri (L.) and has anti-inflammatory and anti-oxidative properties. It also inhibits the proliferation of hepatocellular carcinoma cells. This study aimed to evaluate the osthole suppressive nonalcoholic fatty liver disease effects in oleic acid (OA)- induced hepatic steatosis and if it can modulate inflammatory responses and oxidative stress. FL83B cell s were pretreated with OA (250μΜ) for 24h, and then added different concentrations of osthole (3-100μM) for 24h. Subsequently, lipolysis and transcription factors of adipogenesis and phosphorylation of AMP-activated protein kinase proteins were measured. In addition, cells with OA - induced steatosis were H2O2 - stimulated, and then incubated with osthole to evaluated if it could suppress its progression to steatohepatitis. Osthole significantly enhanced glycerol release and lipolysis protein expression. Osthole also promoted phosphorylation of AMP-activated protein kinases and increased the activity of triglyceride lipase and hormone- sensitive lipase. Osthole suppressed the nuclear transcription factor kappa-B and the p38 mitogen-activated protein kinase pathway, and decreased the malondialdehyde concentration in FL83B cells with OA - induced steatosis that were treated with H2O2. These results suggest that osthole might suppress nonalcoholic fatty liver disease by decreasing lipid accumulation, and through its anti-oxidative and anti-inflammatory effects via blocked NF-κB and MAPK signaling pathways.
28448873	0	7	Osthole	T109,T121	C0069679
28448873	8	18	attenuates	T052	C0599946
28448873	19	37	lipid accumulation	T033	C0333574
28448873	39	48	regulates	T038	C1327622
28448873	53	63	expression	T045	C1171362
28448873	67	89	inflammatory mediators	T121	C0243042
28448873	95	104	increases	T081	C0205217
28448873	105	117	antioxidants	T121	C0003402
28448873	121	132	FL83B cells	T025	C0007634
28448873	133	140	Osthole	T109,T121	C0069679
28448873	153	174	Cnidium monnieri (L.)	T002	C1042483
28448873	183	200	anti-inflammatory	T080	C1515999
28448873	205	230	anti-oxidative properties	T039	C3179302
28448873	240	248	inhibits	T052	C3463820
28448873	253	266	proliferation	T169	C1514485
28448873	270	294	hepatocellular carcinoma	T191	C2239176
28448873	295	300	cells	T025	C0007634
28448873	335	342	osthole	T109,T121	C0069679
28448873	343	354	suppressive	T169	C0205367
28448873	355	387	nonalcoholic fatty liver disease	T047	C0400966
28448873	388	395	effects	T080	C1280500
28448873	399	409	oleic acid	T109,T121	C0028928
28448873	411	413	OA	T109,T121	C0028928
28448873	416	423	induced	T169	C0205263
28448873	424	441	hepatic steatosis	T047	C2711227
28448873	465	487	inflammatory responses	T046	C1155266
28448873	492	508	oxidative stress	T049	C0242606
28448873	510	520	FL83B cell	T025	C0007634
28448873	528	538	pretreated	T052	C3539076
28448873	544	546	OA	T109,T121	C0028928
28448873	579	588	different	T080	C1705242
28448873	589	603	concentrations	T081	C1446561
28448873	607	614	osthole	T109,T121	C0069679
28448873	648	657	lipolysis	T040	C0023796
28448873	662	683	transcription factors	T116,T123	C0040648
28448873	687	699	adipogenesis	T044	C0596843
28448873	704	719	phosphorylation	T044	C0031715
28448873	723	760	AMP-activated protein kinase proteins	T116,T126	C2350345
28448873	766	774	measured	T080	C0444706
28448873	789	794	cells	T025	C0007634
28448873	800	802	OA	T109,T121	C0028928
28448873	805	812	induced	T169	C0205263
28448873	813	822	steatosis	T046	C0152254
28448873	828	832	H2O2	T121,T130,T197	C0020281
28448873	835	845	stimulated	T070	C1948023
28448873	856	865	incubated	T059	C1439852
28448873	871	878	osthole	T109,T121	C0069679
28448873	904	912	suppress	T169	C1260953
28448873	917	928	progression	T169	C0449258
28448873	932	947	steatohepatitis	T047	C2711227
28448873	949	956	Osthole	T109,T121	C0069679
28448873	971	979	enhanced	T052	C2349975
28448873	980	988	glycerol	T109,T121,T123	C0017861
28448873	989	996	release	T169	C1283071
28448873	1001	1010	lipolysis	T040	C0023796
28448873	1011	1029	protein expression	T045	C1171362
28448873	1031	1038	Osthole	T109,T121	C0069679
28448873	1053	1068	phosphorylation	T044	C0031715
28448873	1072	1101	AMP-activated protein kinases	T116,T126	C2350345
28448873	1106	1115	increased	T081	C0205217
28448873	1120	1151	activity of triglyceride lipase	T044	C2262029
28448873	1156	1181	hormone- sensitive lipase	T044	C2266414
28448873	1183	1190	Osthole	T109,T121	C0069679
28448873	1191	1201	suppressed	T169	C1260953
28448873	1206	1242	nuclear transcription factor kappa-B	T116,T129	C0079904
28448873	1251	1287	p38 mitogen-activated protein kinase	T116,T126	C1120843
28448873	1288	1295	pathway	T044	C1704259
28448873	1301	1310	decreased	T081	C0205216
28448873	1315	1330	malondialdehyde	T109,T123	C0024643
28448873	1331	1344	concentration	T081	C1446561
28448873	1348	1359	FL83B cells	T025	C0007634
28448873	1365	1367	OA	T109,T121	C0028928
28448873	1370	1377	induced	T169	C0205263
28448873	1378	1387	steatosis	T046	C0152254
28448873	1398	1410	treated with	T169	C1522326
28448873	1411	1415	H2O2	T121,T130,T197	C0020281
28448873	1444	1451	osthole	T109,T121	C0069679
28448873	1458	1466	suppress	T169	C1260953
28448873	1467	1499	nonalcoholic fatty liver disease	T047	C0400966
28448873	1514	1532	lipid accumulation	T033	C0333574
28448873	1550	1564	anti-oxidative	T039	C3179302
28448873	1569	1594	anti-inflammatory effects	T080	C1515999
28448873	1599	1606	blocked	T169	C0332206
28448873	1607	1612	NF-κB	T116,T129	C0079904
28448873	1617	1640	MAPK signaling pathways	T043	C1518102